Clinical trial
Effects of Metabolic Status on the Risk, at 5 Years, of Cardiovascular Events, Chronic Kidney Disease in Two Caribbean and Polynesian Populations With Morbid Obesity. Contribution of the "OBECAM" Cohort, for the Study of Obesity
NCT07830030 is registered in ClinicalTrials.gov with Clinique as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Metabolic Status on the Risk, at 5 Years, of Cardiovascular Events, Chronic Kidney Disease in Two Caribbean and Polynesian Populations With Morbid Obesity. Contribution of the "OBECAM" Cohort, for the Study of Obesity
- Lead sponsor
- Clinique
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 3, 2025
- Completion date
- December 31, 2030
- Enrollment
- 480 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease (stage 3-4), morbid obesity